Novel oral anticoagulants are alternative medicines for warfarin and other vitamin-K antagonists.NOACs offer potential advantages over VKAs,such as rapid onset of action,short half-life,do not require regular monitoring and fewer drug and food interactions.NOACs are used for the prevention of ischemic stroke and systemic embolism in patients with non-valvular atrial fibrillation.The time of NOACs are used in clinical is short,this article reviews some studies involving major adverse reactions of NOACs and some common adverse reactions of NOACs.Designed to provide a reference for clinical safety and effective drug use. |